Goose Parvovirus and Derzsy Disease

Overview and Taxonomy of Goose Parvovirus and Derzsy Disease

Historical Context and Economic Significance

Goose parvovirus (GPV), the etiological agent of Derzsy’s disease, also historically referred to as gosling plague, represents one of the most economically consequential viral pathogens affecting global waterfowl production. First recognized in the early 1960s, Derzsy’s disease has since been documented across major poultry-producing regions worldwide, resulting in substantial losses to the goose meat industry and, more recently, to duck production sectors [1, 13]. The disease is classified as a notifiable condition by the World Organisation for Animal Health (WOAH) in several European nations, including Poland, which stands as the continent’s foremost goose producer [8]. The imperative for official reporting underscores the profound epizootic threat that GPV poses to commercial waterfowl farming operations.

The impact of Derzsy’s disease is particularly devastating in young birds. Mortality rates among goslings during the first week of life can reach 90%, with susceptibility extending through the first three to four weeks post-hatch [3, 13]. This extraordinary virulence in neonatal birds has driven intensive research into viral pathogenesis, host-virus interactions, and the development of prophylactic interventions including live attenuated vaccines, inactivated vaccines, and novel recombinant vaccine platforms [3, 13]. Beyond the immediate mortality, GPV infection in surviving birds frequently results in growth retardation, locomotor disturbances, and reduced marketability, creating a compounding economic burden that extends well beyond acute disease losses [13, 16].

The epidemiological landscape of GPV has evolved considerably since its initial description. While classical Derzsy’s disease primarily afflicted domestic geese and Muscovy ducks, the emergence of novel GPV variants with expanded host tropism has fundamentally altered the disease ecology. The recognition of short beak and dwarfism syndrome (SBDS) in Cherry Valley ducks, mule ducks, and Pekin ducks, caused by novel goose parvovirus (NGPV) strains, has extended the host range and geographic distribution of GPV-associated disease [16-18]. This syndrome, characterized by beak deformity, growth retardation, and reduced feed conversion efficiency, was first documented in China in 2015 and has since been reported in Egypt and Poland, illustrating the transcontinental dissemination of these emerging variants [17, 18].

Taxonomic Classification and Genomic Architecture

Goose parvovirus is classified within the genus Dependoparvovirus of the subfamily Parvovirinae, family Parvoviridae [12, 13]. This taxonomic placement is significant because dependoparvoviruses have historically been characterized by their requirement for helper virus co-infection for productive replication, a feature that distinguishes them from autonomous parvoviruses. However, GPV demonstrates the capacity for autonomous replication in susceptible waterfowl hosts, a characteristic that has been leveraged in the development of infectious clone systems and reverse genetics approaches [10, 12]. The genus Dependoparvovirus encompasses a diverse array of vertebrate-infecting viruses, including the human adeno-associated viruses (AAVs) and several avian parvoviruses. Structural comparison of the GPV capsid with human AAV2, AAV5, and quail AAV (QAAV) has revealed conserved parvoviral architectural features, including surface two-fold depressions, three-fold protrusions, and five-fold channels, while also identifying unique conformations in several surface-accessible variable regions (VRs) that may dictate host specificity and antigenic properties [2].

The GPV genome is a linear, single-stranded DNA molecule of approximately 5,100 nucleotides, flanked by inverted terminal repeats (ITRs) that form palindromic hairpin structures essential for viral replication [7, 11]. The genome is organized into two major coding regions: the left open reading frame encoding the nonstructural proteins (Rep1 and Rep2) involved in viral replication, and the right open reading frame encoding the structural viral proteins VP1, VP2, and VP3 that constitute the icosahedral capsid [7, 15]. The VP3 protein, which forms the core structural component of the capsid, is the most conserved among the capsid proteins and serves as the primary target for diagnostic detection and vaccine development [3, 8]. Comparative sequence analysis of waterfowl parvoviruses has demonstrated that GPV and Muscovy duck parvovirus (MDPV) share approximately 77% nucleotide identity and 84.6% amino acid identity in their capsid proteins, with the greatest divergence concentrated in the N-terminal region of VP2 preceding the VP3 initiation codon, where amino acid identity falls to only 35% [15].

Genetic Diversity and Strain Classification

The genetic landscape of GPV has undergone significant expansion with the increasing application of molecular characterization techniques. Phylogenetic analyses based on complete genomic sequences, as well as individual gene segments including VP1, VP3, and the nonstructural Rep genes, have revealed substantial heterogeneity among global GPV isolates [1, 5, 14]. Field strains circulating in Turkey during the 2019 outbreak were found to cluster with European group 2 variants, demonstrating the transcontinental circulation of GPV and the capacity for viral dissemination between Asia and Europe [1]. Similarly, molecular characterization of GPV isolates from Turkish geese confirmed the presence of virulent strains, reinforcing the continued relevance of Derzsy’s disease in regions where waterfowl production remains economically important [5].

The emergence of NGPV as a distinct genetic lineage has necessitated a reexamination of waterfowl parvovirus taxonomy. NGPV strains associated with SBDS in ducks form a monophyletic cluster that is genetically intermediate between classical GPV and MDPV, sharing nucleotide identities of 95.7–96.6% with classical GPV strain B of Derzsy’s disease and 74.1–74.6% with MDPV strain FM [4]. Complete genome sequencing of NGPV isolates from Poland revealed 98.57–99.28% identity with Chinese NGPV sequences and 96.42% identity with classical GPV, confirming the transcontinental spread of this emerging lineage and its genetic distinctiveness from traditional GPV strains [18]. The rate of amino acid mutations in the Rep protein was found to be higher than in the VP1 protein when comparing NGPV to classical GPV, suggesting differential evolutionary pressures acting on the replication and structural components of the virus [18].

Recombination events between GPV and MDPV have been documented, further complicating the taxonomic framework. The MDPV strain ZW was identified as a recombinant virus, with the majority of its genome derived from classical MDPV but containing two recombination sites, one surrounding the P9 promoter and another situated in the middle of the VP3 gene, that originated from both virulent GPV strains and the vaccine strain SYG61v [7]. This finding has profound implications for both vaccine safety and virus evolution, as recombination between vaccine and field strains could generate novel variants with altered pathogenicity or host range. Sequence analysis of the inverted terminal repeat region has additionally revealed deletions characteristic of different lineages, including a 14-nucleotide deletion in NGPV strains compared to classical GPV, which may contribute to differences in replication efficiency and virulence [14].

Structural Biology and Host-Virus Interactions

The application of cryogenic electron microscopy (cryo-EM) has revolutionized our understanding of GPV capsid architecture. The recently resolved GPV capsid structure at 2.4 Å resolution has provided unprecedented detail into the molecular organization of the viral particle and its antigenic properties [2]. The capsid exhibits the canonical parvoviral T=1 icosahedral symmetry, with 60 copies of the viral protein subunits arranged to form the characteristic surface topology. Structural comparison with other dependoparvoviruses revealed that variable region III (VR-III) may be particularly important for GPV and MDPV infection, potentially serving as a determinant of host cell tropism [2]. The GPV capsid demonstrates thermal stability at physiological pH but exhibits reduced stability under acidic conditions, which may influence viral persistence in the environment and transmission dynamics [2].

The nuclear import of viral components is a critical step in the GPV life cycle, and recent studies have identified the nuclear localization signal (NLS) required for VP1 translocation. A basic region (BR) spanning residues 160–171 (YPVVKKPKLTEE) in the N-terminus of VP1 was found to function as a potent NLS capable of mediating nuclear import of both small and large reporter proteins [12]. Mutagenesis experiments demonstrated that three lysine residues, positions 164, 165, and 167, are absolutely required for nuclear localization of VP1, and substitution of these residues with alanine completely abrogates viral proliferation in goose embryo fibroblasts (GEFs) [10, 12]. This mechanistic insight into the molecular requirements for GPV replication provides potential targets for antiviral intervention and underscores the sophisticated interplay between viral structural proteins and the host cellular machinery.

Pathobiological Diversity and Clinical Spectrum

The clinical manifestations of GPV infection have expanded considerably with the recognition of new host species and viral variants. Classical Derzsy’s disease in goslings and Muscovy ducklings presents as an acute, highly fatal illness characterized by depression, anorexia, diarrhea, and locomotor disturbance, with pathological findings including myocardial degeneration, intestinal necrosis, myocarditis, perihepatitis, and ascites [6, 9, 13]. Co-infection with other waterfowl pathogens, such as goose astrovirus, can exacerbate disease severity and produce novel clinical presentations, including visceral gout, joint swelling, and extensive heterophil myelocyte infiltration into multiple organs [6]. The pathological lesions in immune organs following GPV infection include lymphocyte necrosis in the thymus and spleen, with widespread viral replication and dissemination detectable in the cecal tonsil, spleen, Harderian gland, peripheral blood lymphocytes, and bone marrow [9].

Perhaps the most remarkable recent finding is the association of GPV with angel wing syndrome in Muscovy ducks. This condition, historically attributed to dietary, environmental, and hereditary causes, has now been demonstrated to be inducible by GPV infection. Experimental oral inoculation of Muscovy ducks with GPV strain HS1 reproduced both typical GPV clinical signs and angel wing syndrome, providing the first documented evidence of a viral etiology for this debilitating wing deformity [4]. The HS1–HS4 strains clustered within a distinct monophyletic group relative to both classical Derzsy’s disease strains and SBDS-associated strains, suggesting that specific genetic determinants may confer the capacity to induce angel wing pathology [4]. This finding fundamentally expands our understanding of GPV pathogenesis and highlights the capacity of this virus to produce diverse clinical outcomes depending on host species and viral genotype.

Molecular Pathogenesis: Capsid Structure, Antigenicity, and Virulence Determinants

The molecular pathogenesis of goose parvovirus (GPV) is fundamentally governed by the intricate architecture of its icosahedral capsid, the antigenic landscape presented to the host immune system, and a constellation of genetic determinants that modulate viral replication, tissue tropism, and disease severity. As a member of the genus Dependoparvovirus within the family Parvoviridae, GPV exhibits a non-enveloped capsid approximately 22–26 nm in diameter, assembled from 60 copies of overlapping viral proteins (VPs) derived from a single open reading frame. The capsid serves not merely as a protective shell for the single-stranded DNA genome but as a dynamic interface mediating host cell receptor attachment, endosomal escape, nuclear trafficking, and immune evasion. Understanding the molecular underpinnings of these processes is critical for rational vaccine design, therapeutic intervention, and epidemiological surveillance, particularly given the substantial economic losses inflicted by Derzsy’s disease on the global waterfowl industry, as recognized by the World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) of the United Nations.

Capsid Architecture at Atomic Resolution

The determination of the GPV capsid structure by cryogenic electron microscopy (cryo-EM) at an unprecedented resolution of 2.4 Å has revolutionized our understanding of its molecular organization [2]. This high-resolution reconstruction reveals a capsid that, while adhering to the canonical parvovirus core fold of a β-barrel jelly-roll motif, possesses unique structural embellishments that distinguish it from both human adeno-associated viruses (AAVs) and other avian dependoparvoviruses. The outer surface is characterized by prominent three-fold protrusions, shallow two-fold depressions, and cylindrical channels at the five-fold axes [2]. These five-fold channels are of particular functional significance, as they serve as portals for the externalization of the VP1 unique region (VP1u) during cell entry, a critical step for phospholipase A2 (PLA2) activity and endosomal escape. The GPV capsid demonstrates remarkable thermal stability at physiological pH (pH 7.4), yet exhibits significantly reduced stability under acidic conditions (pH 4.0–5.0) [2]. This pH-dependent destabilization is not a structural weakness but a strategically evolved mechanism: the acidic environment of late endosomes triggers conformational changes that facilitate VP1u exposure and subsequent membrane penetration, a hallmark of parvoviral entry pathways.

Comparative structural analysis with human AAV2, AAV5, and quail AAV (QAAV) has identified several surface-accessible variable regions (VRs) that dictate host range and antigenic specificity [2]. Among these, VR-III emerges as a particularly critical determinant for GPV and its close relative, Muscovy duck parvovirus (MDPV). This loop region, located on the capsid surface near the three-fold protrusions, exhibits pronounced conformational differences between GPV and the AAV serotypes, likely contributing to the restricted host tropism of GPV for anseriform species. Furthermore, the VR-III region has been implicated in receptor recognition, as its topology corresponds to the sialic acid-binding sites identified in other parvoviruses. Although the cognate cellular receptor for GPV remains unidentified, the structural data strongly suggest that glycan interactions mediated by VR-III and adjacent surface loops govern initial attachment to host cells, a hypothesis supported by the observation that GPV infects geese and Muscovy ducks but not mammalian cells.

The structural comparison of GPV with other bird dependoparvoviruses further reinforces the importance of VR-III in species-specific infection [2]. While the core capsid scaffold is highly conserved, the surface loops are hypervariable, evolving under selective pressure from host immune responses and receptor diversity. This evolutionary plasticity is evident when comparing classical GPV strains causing Derzsy’s disease with novel GPV (NGPV) variants responsible for short beak and dwarfism syndrome (SBDS) in ducks. Although the capsid architecture remains largely intact, discrete amino acid substitutions within VR-III and other surface loops likely alter receptor-binding preferences, enabling NGPV to infect Pekin ducks and Cherry Valley ducks, species that are less susceptible to classical GPV [16-18].

Antigenic Determinants and Host Immune Interface

The antigenic landscape of the GPV capsid is dominated by the major capsid protein VP3, which constitutes approximately 80% of the virion mass and forms the core of the icosahedral shell. VP3 is generated by proteolytic cleavage of VP2 during virion maturation, a common feature among parvoviruses that stabilizes the capsid and modulates antigenicity. The immunodominant nature of VP3 has been harnessed for diagnostic and vaccine development. Recombinant VP3 fragments, particularly a 32.3 kDa protein encompassing epitopes 4–6 (VP3ep4–6), have demonstrated superior sensitivity and specificity for detecting anti-GPV antibodies in goose sera via indirect ELISA, outperforming the smaller VP3ep6 fragment [8]. This region likely contains linear B-cell epitopes recognized by the humoral immune system, and its high conservation among GPV field strains makes it an ideal target for serological surveillance.

However, antigenic variation is not negligible. Sequence analysis of GPV capsid proteins from isolates collected between 1990 and 1999 revealed amino acid divergence of 4.1–4.4%, with variant residues clustering in two discrete regions of VP3: residues 203–266 and 482–534 [15]. These hotspots of variability overlap with surface-exposed loops predicted to be solvent-accessible on the intact virion, consistent with their role as targets of neutralizing antibodies. The concentration of non-synonymous mutations in these regions provides compelling evidence for positive selection driven by host immune pressure. In the context of Derzsy’s disease outbreaks, such antigenic drift, even if subtle, can occasionally lead to vaccine breakthrough, emphasizing the necessity for ongoing molecular surveillance. Indeed, field strains from the 2019 outbreak in Turkey displayed a series of unique amino acid substitutions in the VP3 region that distinguished them from vaccine strains, potentially affecting virulence and antigenic match [1].

The humoral immune response to GPV is primarily directed against conformational epitopes displayed on the intact capsid, as is typical for parvoviruses. The VP1u, although not part of the mature capsid surface, contains immunogenic regions that are exposed only transiently during cell entry. This cryptic nature makes VP1u antibodies less abundant but highly neutralizing, as they can block the essential PLA2 activity. The development of cross-reactive antibodies is an intriguing aspect of GPV antigenicity. Remarkably, the GPV capsid can be bound by cross-reactive anti-AAV capsid antibodies that recognize the five-fold region of the virus, as demonstrated by native immuno-dot blot analysis [2]. This finding suggests the existence of conserved structural epitopes shared among diverse dependoparvoviruses, potentially reflecting a common ancestral capsid fold or convergent evolution at functionally constrained sites. Such cross-reactivity has implications for the use of AAV-based vectors in gene therapy, as pre-existing antibodies in avian species might neutralize these vectors, although the practical significance for mammalian applications remains to be determined.

At the cellular level, the humoral and mucosal immune responses against GPV are critical for protection. Recombinant Lactobacillus casei expressing the VP3 protein has been shown to induce both systemic (IgG) and mucosal (secretory IgA) antibody responses in goslings following oral immunization [3]. This approach leverages the immunostimulatory properties of the lactic acid bacterium to present VP3 to the gut-associated lymphoid tissue, mirroring the natural route of GPV infection. The induced antibodies are capable of neutralizing viral infectivity, and although the protection rate (30%) was modest in challenge experiments, it matched that of a commercial vaccine [3]. These data underscore the importance of VP3 as a protective antigen and highlight the potential of mucosal vaccination strategies for combating Derzsy’s disease.

Molecular Determinants of Virulence and Host Tropism

Virulence in GPV is a multifactorial trait encoded within both the non-structural and structural regions of the genome, as well as the cis-acting inverted terminal repeats (ITRs). The VP1 protein, which contains the essential PLA2 domain and a nuclear localization signal (NLS), is a critical virulence determinant. Using a PCR-based reverse genetics system, researchers have demonstrated that residues K164, K165, and K167 within the NLS motif (160YPVVKKPKLTEE171) are absolutely required for VP1 nuclear import [10, 12]. Substitution of any of these lysine residues with alanine (K164A, K165A, or K167A) completely abrogates VP1 nuclear localization, as visualized by immunofluorescence, and renders the recombinant virus incapable of proliferation in goose embryo fibroblasts (GEFs) [10]. The mechanistic basis for this is clear: without nuclear entry of VP1, the viral genome cannot be delivered to the nucleus for replication, and progeny virions cannot be assembled. This finding positions the VP1 NLS as a non-redundant virulence factor and a potential target for attenuated vaccine development.

Beyond VP1, the ITR regions play a pivotal role in viral replication and pathogenicity. The left ITR contains cis-acting elements, including an E-box motif (CACATG) at nucleotide position 287, which serves as a binding site for host transcription factors that regulate cell cycle progression. Deletion of this E-box motif from the infectious clone of a virulent Muscovy duck-origin GPV (MDGPV) strain resulted in a mutant virus (r-PTΔE287) with markedly reduced replication capacity and attenuated virulence in vivo [11]. The molecular mechanism underlying this attenuation involves cell cycle dysregulation. Infection with the wild-type virus promotes transition from G0/G1 to S phase, providing the cellular replication machinery necessary for parvoviral genome replication. The E-box deletion mutant, however, induces G0/G1 phase arrest, preventing S phase entry and thereby limiting viral DNA synthesis and progeny production [11]. This elegant interplay between a viral cis-element and the host cell cycle machinery exemplifies the sophistication of GPV-host interactions and provides a clear molecular basis for virulence attenuation.

Recombination between GPV and MDPV represents another mechanism driving virulence evolution and host range expansion. The identification of MDPV strain ZW as a natural recombinant revealed that approximately 30% of its genome, including a large segment of the VP3 gene, originated from GPV, while the remainder derived from classical MDPV [7]. This recombination event involved both virulent field strains (YZ99-6 and B) and a vaccine strain (SYG61v) of GPV, indicating that live attenuated vaccines can contribute to the emergence of novel recombinants when co-circulating with field viruses. The recombination breakpoints occurred at the P9 promoter region and within the VP3 gene, suggesting that the VP3 gene of GPV confers a selective advantage in Muscovy ducks, possibly by enhancing receptor binding or immune evasion. The emergence of NGPV strains causing SBDS further illustrates the adaptive plasticity of GPV. These variants possess characteristic deletions in the ITR region (14-nucleotide deletions compared to classical GPV strain B) and specific amino acid substitutions in the Rep and VP1 proteins that correlate with altered tissue tropism and reduced mortality but increased morbidity in ducks [14, 16-18].

The correlation between viral load, age, and clinical severity provides a quantitative framework for understanding GPV virulence. Real-time PCR analysis of field samples has established a significant inverse correlation between age and viral DNA copy number in the heart and liver of infected geese and Muscovy ducks [19]. Younger birds (1–2 weeks old) harbor viral loads up to several orders of magnitude higher than older birds, which correlates directly with the near 90% mortality observed in goslings under 7 days of age. Conversely, infection in older birds or with attenuated strains results in lower viral replication and subclinical or mild disease [19]. This age-dependent susceptibility is likely multifactorial, reflecting the immaturity of the neonatal immune system, the higher proportion of dividing cells (which are required for parvoviral replication) in growing tissues, and potentially age-related differences in receptor expression.

The dissemination of GPV within the host is extensive, with viral antigen and nucleic acid detected in multiple immune organs, including the thymus, spleen, bursa of Fabricius, Harderian gland, cecal tonsil, and bone marrow [9]. The spleen harbors the highest viral load at 7 days post-infection, indicating that this organ is a major site of viral replication and immune interaction [9]. The extensive lymphocyte necrosis observed in the thymus and spleen accounts for the profound immunosuppression that accompanies severe Derzsy’s disease, predisposing birds to secondary infections such as astrovirus, which exacerbates pathology and mortality [6]. The ability of GPV to replicate in immune cells and induce apoptosis is a key virulence determinant, as it cripples the host's ability to mount an effective antiviral response. This immune evasion strategy is compounded by the induction of angel wing syndrome in Muscovy ducks, a developmental deformity linked to GPV infection that suggests the virus can interfere with connective tissue or bone growth signaling pathways, further broadening its pathogenic repertoire [4].

Genetic Diversity and Global Epidemiology of Goose Parvovirus Strains

The genetic landscape of goose parvovirus (GPV) is a dynamic and increasingly complex tapestry, reflecting the virus’s long evolutionary history, its adaptation to multiple waterfowl hosts, and the selective pressures imposed by vaccination and geographic isolation. As the etiological agent of Derzsy’s disease, GPV has been recognized for over six decades, yet the past two decades have witnessed an explosion in our understanding of its genetic diversity, driven by the widespread application of molecular sequencing and phylogenetic analysis. This section provides an exhaustive examination of the genetic variability among GPV strains, the emergence of novel variants, and the global epidemiological patterns that define the current distribution of this economically devastating pathogen. The World Organisation for Animal Health (WOAH) classifies Derzsy’s disease as a significant transboundary disease of waterfowl, underscoring the critical need for continuous genomic surveillance to track the emergence and spread of pathogenic variants.

Phylogenetic Architecture and the Emergence of Distinct Lineages

Early molecular characterization of GPV relied primarily on sequencing of the VP1 and VP3 capsid genes, revealing a relatively conserved virus with limited genetic drift. However, as sequencing efforts expanded globally, a far more intricate phylogenetic structure has emerged. Classical GPV (cGPV) strains, responsible for the acute, highly lethal Derzsy’s disease in goslings and Muscovy ducklings, form a distinct clade. Within this clade, further sub-lineages have been identified, often correlating with geographic origin. For instance, studies from Turkey have demonstrated that field strains circulating during the 2019 outbreak clustered with European group 2 variants, confirming the transcontinental movement of GPV between Asia and Europe [1]. This finding is corroborated by molecular characterization of GPV in Turkish geese, which identified virulent strains with high similarity to European isolates, suggesting a shared genetic pool that transcends continental boundaries [5].

A major paradigm shift in GPV genetics occurred with the emergence and characterization of novel goose parvovirus (NGPV), the causative agent of short beak and dwarfism syndrome (SBDS) in ducks. Initially observed in mule ducks in France in the 1970s and later re-emerging in China around 2015, NGPV represents a distinct genetic lineage that has undergone significant evolutionary divergence from cGPV [14, 16]. Phylogenetic analyses consistently demonstrate that NGPV strains form a separate, monophyletic branch, distinct from both cGPV and classical Muscovy duck parvovirus (MDPV) [4, 14]. The genetic distance between NGPV and cGPV is substantial, with nucleotide identities in the VP1 gene typically ranging from 95.7% to 97.4% when compared to cGPV strain B, while identities with MDPV are significantly lower, at approximately 74.1%–74.6% [4]. This degree of divergence is not merely a reflection of geographic isolation but indicates a fundamental shift in host tropism and pathogenic potential. The emergence of NGPV in China, followed by its rapid spread to Egypt and Poland, exemplifies a critical epidemiological event: the adaptation of a goose-adapted virus to a new host (Pekin ducks) with a dramatically altered clinical presentation [17, 18].

Molecular Determinants of Genetic Variation: The VP1 and VP3 Genes

The genetic diversity of GPV is not uniformly distributed across the genome. The non-structural protein (Rep) and structural protein (VP1/VP2/VP3) genes exhibit different rates of evolution, with the capsid genes, particularly VP3, being a major hotspot for variation. The VP3 protein constitutes the core of the viral capsid and is the primary target for host immune responses. Comparative analyses have revealed that the most variable region between GPV and MDPV resides in the N-terminal portion of VP2, before the initiation codon of VP3, where amino acid divergence can reach 35% [15]. Within the VP3 gene itself, variant amino acids cluster in specific regions, notably residues 203-266 and 482-534 [15]. Crucially, these hypervariable regions overlap with surface-exposed loops on the three-dimensional structure of the parvovirus capsid, as elucidated by cryo-electron microscopy (cryo-EM) [2]. This structural mapping strongly implies that these variable regions are under selective pressure from the host immune system, likely representing sites of neutralizing antibody binding. The identification of variable region III (VR-III) as a key determinant for GPV and MDPV infection further underscores the functional importance of these surface-exposed loops in host cell recognition and entry [2].

The VP1 gene, which contains the unique N-terminal region (VP1u) essential for nuclear localization and genome packaging, also harbors critical genetic determinants of viral fitness. A landmark study identified a basic region (BR) at residues 160-171 (YPVVKKPKLTEE) within VP1u that functions as a nuclear localization signal (NLS) [12]. Site-directed mutagenesis revealed that the lysine residues at positions 164, 165, and 167 are absolutely required for the nuclear import of VP1 and, consequently, for viral proliferation in goose embryo fibroblasts (GEFs) [10, 12]. Mutations at these positions completely abrogated viral rescue and replication, demonstrating that even single amino acid changes in critical functional domains can have profound effects on viral viability. This level of functional constraint explains why certain regions of the genome remain highly conserved across diverse GPV isolates, while other regions, such as the surface loops of VP3, are free to accumulate mutations under immune selection.

Recombination as a Major Driver of Genetic Diversity

Beyond point mutations, recombination has emerged as a powerful force shaping the genetic diversity and evolution of waterfowl parvoviruses. The co-circulation of GPV and MDPV in mixed waterfowl populations creates opportunities for genetic exchange. The most compelling evidence for this comes from the characterization of the MDPV strain ZW, isolated from a deceased Muscovy duckling in China in 2006 [7]. Recombination analysis revealed that strain ZW is a chimeric virus, with the bulk of its genome originating from a classical MDPV strain (YY) acting as the major parent, while two virulent GPV strains (YZ99-6 and B) and, remarkably, a GPV vaccine strain (SYG61v) served as minor parents [7]. Two distinct recombination breakpoints were identified: a small site surrounding the P9 promoter and a larger site situated in the middle of the VP3 gene [7]. The involvement of a vaccine strain in this recombination event is particularly alarming, as it raises the specter of live attenuated vaccines contributing to the emergence of novel, potentially more virulent recombinants. This finding has profound implications for vaccine safety and the design of future control strategies, emphasizing the need for non-replicating or subunit vaccines.

Further evidence of recombination comes from studies on the inverted terminal repeats (ITRs). The ITRs are critical cis-acting elements required for viral DNA replication and packaging. A study on Muscovy duck-origin goose parvovirus (MDGPV) demonstrated that a deletion of an E-box motif (CACATG) within the left ITR (L-ITR) at nucleotide 287 resulted in a rescued mutant virus with reduced replication ability and altered cell cycle regulation [11]. The mutant virus induced G0/G1 phase arrest in infected cells, which in turn inhibited viral replication and progeny production [11]. This finding highlights how even small genetic changes in non-coding regulatory regions can have profound effects on viral fitness and pathogenesis. The ITR region is also a site of length variation; NGPV strains isolated from growing period geese and Cherry Valley ducks in China were found to have two 14-nucleotide deletions compared to the classical GPV virulent B strain, and one 14-nucleotide deletion compared to mule duck-origin NGPV [14]. These deletions likely influence the stability and replication efficiency of the viral genome, contributing to the distinct biological properties of NGPV.

Global Epidemiology: From Endemicity to Emergence

The global epidemiology of GPV is characterized by a complex interplay of endemic circulation, transcontinental spread, and host-switching events. Historically, Derzsy’s disease was considered a disease of geese and Muscovy ducks, with outbreaks reported across Europe and Asia. The disease is enzootic in many countries with significant waterfowl industries, including China, Poland, Hungary, and Turkey [1, 5, 8, 14]. In Poland, the leading goose producer in Europe, Derzsy’s disease is a notifiable condition due to its severe economic impact, and surveillance programs rely on both serological monitoring using ELISA and molecular detection via PCR and LAMP [8, 20]. The development of quantitative real-time PCR assays targeting the ITR region has enabled researchers to correlate viral DNA copy number with clinical symptoms and age, providing a powerful tool for estimating disease severity and stage of infection [19]. This quantitative approach has revealed that viral loads are highest in the spleen at 7 days post-infection (dpi) in experimentally infected ducklings, followed by bone marrow and peripheral blood lymphocytes at 3 dpi, indicating a rapid systemic dissemination [9].

The most significant epidemiological shift in recent years has been the global emergence of NGPV and SBDS. First identified in China around 2015, NGPV rapidly spread to become a major pathogen in Pekin duck flocks, causing stunting, beak atrophy, and significant economic losses despite relatively low mortality [14, 16]. The virus then appeared in Egypt in 2019, where it was isolated from mule and Pekin duck farms, with partial VP1 gene sequencing confirming its close genetic relationship to Chinese NGPV strains [17]. Simultaneously, in 2019, SBDS was documented for the first time in Poland, affecting eight Pekin duck farms [18]. Complete coding region sequencing of Polish NGPV isolates revealed 98.57–99.28% nucleotide identity with Chinese NGPV sequences, providing unequivocal evidence for the introduction of this novel variant into Europe [18]. The rapid intercontinental spread of NGPV, likely facilitated by the international trade of live birds or contaminated poultry products, underscores the inadequacy of current biosecurity measures and the need for enhanced global surveillance networks. The World Health Organization (WHO) and FAO have long emphasized the importance of such networks for emerging infectious diseases, and the NGPV story serves as a textbook example of a pathogen exploiting global trade routes.

Host Range Expansion and Co-infection Dynamics

The genetic diversity of GPV is intimately linked to its expanding host range. While cGPV primarily infects geese and Muscovy ducks, NGPV has demonstrated a remarkable ability to infect Pekin ducks, mule ducks, and Cherry Valley ducks [14, 17, 18]. This host-switching event is associated with specific genetic changes, particularly in the capsid proteins that mediate cell attachment and entry. The structural comparison of GPV capsids with other dependoparvoviruses, including quail AAV, has revealed unique conformations in surface-accessible variable regions that likely dictate host specificity [2]. Furthermore, GPV has been implicated in the induction of angel wing syndrome in Muscovy ducks, a condition previously attributed solely to dietary and environmental factors [4]. Four GPV strains (HS1-HS4) isolated from Muscovy ducks with angel wing syndrome formed a distinct monophyletic group in phylogenetic analyses, and experimental infection with strain HS1 reproduced both GPV clinical signs and angel wing deformity [4]. This finding expands the known pathological spectrum of GPV infection and suggests that certain genetic variants may possess unique pathogenic properties.

Co-infection with other waterfowl pathogens further complicates the epidemiological picture. GPV is frequently detected alongside goose astrovirus, which causes fatal visceral gout in goslings. Co-infected birds exhibit exacerbated clinical signs, including increased mortality, severe enteritis, and extensive infiltration of heterophil myelocytes into multiple organs [6]. Similarly, NGPV infection in Polish Pekin ducks was associated with a high prevalence (85.7%) of duck circovirus co-infection, an immunosuppressive agent that likely exacerbates the severity of SBDS [18]. These co-infection dynamics highlight the importance of considering the broader pathogen community when studying GPV epidemiology and pathogenesis. The genetic diversity of GPV, driven by mutation, recombination, and host adaptation, continues to pose a formidable challenge to the waterfowl industry. Continuous genomic surveillance, coupled with functional studies to map the phenotypic consequences of genetic variation, is essential for predicting future emergence events and developing effective, durable control strategies.

Clinical Manifestations and Pathological Features of Derzsy Disease in Waterfowl

Derzsy disease, caused by goose parvovirus (GPV), represents one of the most economically devastating viral infections affecting global waterfowl production. The disease, recognized by the World Organisation for Animal Health (WOAH) as a significant threat to the poultry industry, manifests through a spectrum of clinical presentations that are intimately tied to the age, species, and immune status of the affected birds. The clinical course and pathological outcomes range from peracute mortality in neonates to chronic, debilitating syndromes in older birds, reflecting a complex interplay between viral virulence factors, host susceptibility, and environmental stressors. Understanding these manifestations in exhaustive detail is critical for timely diagnosis, effective containment, and informed management strategies.

Acute Clinical Manifestations in Neonates

The most characteristic and devastating presentation of Derzsy disease occurs in goslings and Muscovy ducklings during the first three weeks of life, with mortality rates reaching as high as 90% within the first seven days post-hatching [3]. The incubation period is remarkably short, typically ranging from 2 to 5 days following natural exposure, after which a constellation of rapidly progressive signs emerges. Affected birds initially exhibit profound lethargy and anorexia, refusing to feed and congregating in huddles beneath heat sources, indicating a loss of thermoregulatory capacity [6]. This is rapidly followed by locomotor disturbances; birds demonstrate a characteristic reluctance to move, and when forced, display a staggering, uncoordinated gait that frequently progresses to complete recumbency [13].

Ocular and nasal manifestations are among the most frequently reported clinical signs and serve as important diagnostic indicators. Bilateral serous to mucoid ocular discharge, accompanied by pronounced periocular swelling, creates a distinctive "weeping eye" appearance [5]. Conjunctival hyperemia and chemosis are commonly observed upon close examination. Concurrently, a profuse, serous nasal discharge develops, which can accumulate and dry around the nares, leading to partial occlusion and open-mouth breathing [5, 13]. The combination of ocular and nasal involvement, often termed "ocular-nasal syndrome," is a hallmark of acute GPV infection in young birds.

Gastrointestinal signs are invariably present and contribute significantly to mortality through dehydration and electrolyte imbalances. Affected goslings develop profuse, watery, white or yellowish diarrhea, often described as "chalky" in appearance due to the presence of urates [5, 13]. This diarrhea rapidly leads to severe dehydration evidenced by sunken eyes, dry mucous membranes, and loss of skin turgor. Pericloacal soiling with fecal material is a common finding, and the vent area often becomes matted and inflamed. Dysphagia, or difficulty swallowing, has been documented in naturally infected goslings, further compounding the nutritional deficit [5]. In peracute cases, birds may be found dead without any premonitory signs, particularly in flocks where maternally derived antibodies are waning or absent.

Subacute and Chronic Clinical Presentations

In older birds, those beyond three weeks of age, and in less susceptible species such as Cherry Valley ducks or Pekin ducks, the clinical course is frequently subacute or chronic. While mortality is considerably lower, the economic impact remains substantial due to growth retardation, poor feed conversion, and increased culling rates. Affected birds demonstrate a progressive stunting syndrome characterized by a failure to achieve expected body weights. Feathering is often abnormal, with birds retaining down feathers longer than expected and exhibiting ruffled, dirty plumage indicative of poor grooming behavior [14, 18].

A particularly distinctive chronic manifestation in ducks, especially Pekin and mule ducks, is short beak and dwarfism syndrome (SBDS). This syndrome, caused by novel goose parvovirus (nGPV) variants, presents with characteristic beak atrophy and shortening, often accompanied by protrusion of the tongue because the beak is too short to contain it [17, 18]. The beak deformity, combined with generalized growth retardation, renders affected birds unable to compete for feed and water, leading to emaciation and secondary infections. Morbidity rates in SBDS outbreaks typically range from 15% to 40%, with mortality lower (4–6%) but economic losses high due to the unmarketability of affected birds [18]. Importantly, co-infection with duck circovirus, a known immunosuppressive agent, has been documented in 85.7% of SBDS-affected ducks, suggesting that immunosuppression may exacerbate the severity and duration of clinical signs [18].

Angel Wing Syndrome: A Novel Clinical Association

Recent evidence has expanded the recognized clinical spectrum of GPV infection to include angel wing syndrome (AWS) in Muscovy ducks. This condition, historically attributed to dietary, environmental, or hereditary causes, has now been experimentally and epidemiologically linked to GPV infection. Affected ducks present with a characteristic unilateral or bilateral outward rotation of the distal wing joint (carpometacarpal joint), causing the wing to deviate away from the body. In severe cases, the wing may rest horizontally rather than folded against the body [4]. This deformity typically becomes apparent between 2 and 4 weeks of age and may persist into adulthood, impairing mobility and predisposing birds to trauma and secondary infections.

Experimental reproduction of AWS via oral inoculation of Muscovy ducks with GPV strain HS1 confirmed the viral etiology, with clinical signs of both classic GPV infection (lethargy, diarrhea, ocular discharge) and AWS developing concurrently. Interestingly, the severity of AWS was less pronounced in geese compared to Muscovy ducks, suggesting species-specific susceptibility or differential viral tropism affecting bone and joint development [4]. Phylogenetic analysis of AWS-associated isolates (HS1-HS4) revealed these strains cluster within a distinct monophyletic group related to both classical Derzsy disease strains and SBDS strains, with nucleotide identities of 95.7–96.6% to GPV strain B and 96.8–97.4% to SBDS strain JS1603 [4]. This finding underscores the genetic plasticity of GPV and its capacity to induce novel clinical phenotypes.

Gross Pathological Features

The postmortem examination of birds succumbing to Derzsy disease reveals a consistent pattern of gross lesions across multiple organ systems. The carcass is typically dehydrated and emaciated, with muscle atrophy and depletion of subcutaneous and abdominal fat stores. Serous atrophy of epicardial and coronary fat is a frequent observation, indicative of severe catabolic state.

Cardiovascular lesions are among the most striking gross findings. The heart often appears flaccid and dilated, with pale, streaky myocardium suggestive of myocardial degeneration [13]. Pericardial effusion may be present, and in some cases, the pericardial sac is distended with a clear to straw-colored transudate. Ascites, accumulation of serous fluid within the abdominal cavity, is a common associated finding, reflecting right-sided heart failure secondary to myocardial damage [13].

The gastrointestinal tract shows consistent and severe involvement. The intestinal serosa may appear congested and edematous. The lumen of the small intestine, particularly the duodenum and ileum, contains a catarrhal to hemorrhagic exudate. The mucosa is frequently hemorrhagic, ulcerated, or covered with a fibrinous pseudomembrane. In some cases, the duodenum and ileum are markedly swollen and distended with gas and fluid [6]. The liver is typically enlarged, friable, and mottled with pale areas of necrosis, often accompanied by perihepatitis, a fibrinous inflammation of the hepatic capsule [13]. The spleen may be enlarged and congested, with a mottled appearance reflecting lymphoid depletion and necrosis.

A particularly distinctive gross lesion in cases of co-infection with goose astrovirus is the deposition of urates over the surfaces of internal organs, including the heart, liver, and kidneys, a condition known as visceral gout. This finding, while not pathognomonic for GPV alone, is frequently observed in co-infected goslings and reflects renal dysfunction and uric acid accumulation [6].

Histopathological Features and Tissue Tropism

Histopathological examination provides profound insights into the cellular and tissue-level pathogenesis of Derzsy disease. GPV exhibits a pronounced tropism for rapidly dividing cells, particularly those of the lymphoid and hematopoietic systems, explaining the profound immunosuppression and immune organ pathology observed.

In lymphoid organs, the lesions are extensive and devastating. The thymus demonstrates severe lymphocyte depletion within the cortex, with scattered apoptotic lymphocytes (pyknotic nuclear debris) and infiltration of macrophages. The bursa of Fabricius, the primary lymphoid organ in birds, shows marked follicular atrophy, depletion of lymphocytes, and replacement by fibrous connective tissue. In experimentally infected Cherry Valley ducklings, hemorrhagic and congestive lesions were observed in the thymus, spleen, and Harderian gland from as early as 1 day post-infection (dpi), with progressive lymphocyte necrosis in the thymus and spleen [9].

The spleen exhibits multifocal to diffuse necrosis of the periarteriolar lymphoid sheaths, with fibrinoid necrosis of splenic arterioles and congestion of the red pulp. Heterophil myelocyte infiltration into the spleen, as well as the kidney, liver, lung, bursa, and pancreas, is a novel histopathological finding reported in co-infected goslings, reflecting a dysregulated inflammatory response [6]. The Harderian gland, an important component of the ocular immune system, shows congestion, hemorrhage, and lymphoid depletion, correlating with the clinical ocular discharge [9].

In the liver, histopathological changes include diffuse hepatocellular vacuolation (fatty change), multifocal coagulative necrosis, and infiltration of heterophils and mononuclear cells into the parenchyma. An eosinophilic protein-like substance is frequently observed within dilated renal tubules, corresponding to the urate deposition seen grossly [6]. The myocardium demonstrates myofiber degeneration, loss of cross-striations, and interstitial infiltration of inflammatory cells, consistent with viral myocarditis [13].

Quantitative Viral Load and Disease Severity Correlation

The severity of clinical signs and pathological lesions is directly correlated with viral DNA copy number in affected tissues. Quantitative real-time PCR analysis has demonstrated that viral loads are detectable as early as the first week of life, often before the onset of overt clinical signs, making molecular detection a powerful tool for early diagnosis and disease monitoring [19]. In a comprehensive field study, the highest viral loads were consistently identified in the spleen at 7 dpi, followed by the bone marrow, peripheral blood lymphocytes, and cecal tonsil at 3 dpi, and the bursa, Harderian gland, and thymus at 1 dpi [9]. This temporal pattern of viral dissemination confirms that initial replication occurs in lymphoid tissues, followed by systemic spread via infected lymphocytes and monocytes, ultimately reaching parenchymal organs.

The correlation between age, clinical symptoms, and DNA copy number is statistically significant. Younger birds (1–2 weeks of age) exhibit the highest viral loads and the most severe clinical manifestations, while older birds (4+ weeks) show lower viral copy numbers and milder or subclinical disease [19]. This age-dependent susceptibility is likely multifactorial, reflecting immaturity of the immune system, the absence of fully developed lymphoid organs, and the presence of maternally derived antibodies in very young birds from immunized flocks.

Pathological Features of Co-infections

The clinical and pathological picture of Derzsy disease is frequently complicated by co-infections with other waterfowl pathogens, most notably goose astrovirus, duck circovirus, and reovirus. Co-infection with goose astrovirus, a cause of fatal visceral gout in goslings, results in a synergistic exacerbation of pathology. The extensive infiltration of heterophil myelocytes into multiple organs, including the kidney, spleen, liver, lung, bursa, and pancreas, is a unique finding associated with this co-infection and is not typically observed in monoinfections [6]. The presence of urate deposition over serosal surfaces, combined with the classic lesions of Derzsy disease, creates a pathognomonic gross picture that should alert diagnosticians to the possibility of mixed infection.

Similarly, the high prevalence of duck circovirus co-infection in SBDS outbreaks in Poland (85.7% of cases) [18] suggests that circovirus-induced immunosuppression may create a permissive environment for nGPV replication and the expression of more severe clinical phenotypes. The combined immunosuppressive effects of both viruses likely impair the bird’s ability to clear the parvovirus, leading to prolonged viremia, increased viral shedding, and more pronounced growth retardation and beak deformities.

Summary of Pathomechanisms

In summary, the clinical manifestations and pathological features of Derzsy disease in waterfowl are driven by GPV’s profound tropism for actively dividing cells in lymphoid and hematopoietic tissues, leading to severe immunosuppression, systemic viremia, and multi-organ failure. The acute disease in neonates is characterized by peracute mortality, ocular-nasal discharge, locomotor disturbance, and profuse diarrhea. Chronic presentations in older birds manifest as growth retardation, feather abnormalities, and species-specific syndromes such as short beak and dwarfism syndrome in ducks and angel wing syndrome in Muscovy ducks. Grossly, the hallmark lesions are myocardial degeneration, intestinal necrosis, perihepatitis, ascites, and, in co-infections, visceral gout. Histologically, lymphoid depletion, heterophil infiltration, and multi-organ necrosis dominate. The severity of these features is directly correlated with viral load and inversely correlated with host age, providing a robust framework for clinical diagnosis, prognosis, and epidemiological surveillance.

Molecular Diagnostics and Detection Strategies for Goose Parvovirus Infection

The accurate and timely diagnosis of goose parvovirus (GPV) infection is paramount for the effective management of Derzsy's disease, a condition recognized by the World Organisation for Animal Health (WOAH) as a significant threat to waterfowl production systems globally. The high morbidity and mortality rates in goslings and ducklings, coupled with the virus's ability to induce severe economic losses, necessitate a robust arsenal of diagnostic tools. Classical approaches, such as virus isolation in embryonated goose eggs or primary cell cultures like goose embryo fibroblasts (GEFs) [10], alongside histopathological examination of immune organs [6, 9], remain foundational for confirmation. However, the advent of molecular diagnostics has revolutionized the field, offering unparalleled sensitivity, specificity, and speed. These modern strategies are not merely alternatives but are essential for detecting subclinical infections, quantifying viral loads, characterizing emerging variants, and differentiating GPV from its closely related counterparts, such as Muscovy duck parvovirus (MDPV) and the emergent novel goose parvovirus (NGPV) responsible for short beak and dwarfism syndrome (SBDS) [14, 16, 18].

Nucleic Acid Amplification Techniques: The Cornerstone of Molecular Detection

The evolution of nucleic acid amplification tests (NAATs) has provided a spectrum of detection modalities, from conventional endpoint PCR to sophisticated isothermal amplification and next-generation CRISPR-based systems.

Conventional and Real-Time PCR: The polymerase chain reaction (PCR) has long been the workhorse of GPV molecular diagnostics. The design of primer sets targeting conserved genomic regions is critical for reliable detection. For instance, Işıdan et al. [1] designed a novel primer set amplifying a 630-base pair fragment of the VP3 gene to confirm GPV infection during a 2019 outbreak in Turkey, demonstrating the utility of conventional PCR for initial screening and genotyping. The real-time PCR (qPCR) approach, however, provides a quantum leap in diagnostic capability. By enabling the quantification of viral DNA, qPCR allows researchers to correlate viral load with clinical severity and disease progression. Woźniakowski et al. [19] developed a pioneering TaqMan-based real-time PCR targeting the highly conserved inverted terminal repeat (ITR) region, a strategic choice due to its presence in all dependoparvoviruses. This method unified the detection and quantification of both GPV and MDPV. Critically, their work demonstrated a significant correlation between viral DNA copy number in organs like the heart and liver, the age of the bird, and the severity of clinical symptoms. They showed that GPV could be detected in 1-week-old goslings and 2-week-old ducklings before the onset of clinical signs, highlighting the method's value for early surveillance and outbreak containment [19]. This quantitative power has been further applied to study viral pathogenesis; Liu et al. [9] used qPCR to map the temporal distribution of GPV in immune organs of experimentally infected ducklings, finding peak viral loads in the spleen at 7 days post-infection (dpi) and in the bursa of Fabricius as early as 1 dpi, thereby revealing the rapid dissemination of the virus through lymphoid tissues.

Loop-Mediated Isothermal Amplification (LAMP): While PCR requires thermal cycling equipment, LAMP offers a simpler, more rapid, and cost-effective alternative, making it ideal for field deployment or resource-limited settings. Tarasiuk et al. [20] developed a LAMP assay for GPV detection using six specific primers (F3, B3, FIP, BIP, FL, BL) designed against the VP3 gene. The reaction was optimized at a constant temperature of 60°C for only 30 minutes, eliminating the need for a thermocycler. Crucially, the sensitivity of this LAMP assay was reported to be 10-fold higher than conventional PCR [20]. This enhanced sensitivity, combined with its rapid turnaround time and ability to visualize results directly (often by simple turbidity or dye addition), positions LAMP as a powerful point-of-care diagnostic tool for rapid on-farm screening during Derzsy's disease outbreaks.

CRISPR-Based Diagnostics: The Frontier of Sensitivity and Specificity: The most recent breakthrough in GPV molecular diagnostics is the integration of CRISPR/Cas systems. Xiao et al. [21] engineered an optimized diagnostic platform based on the CRISPR/AsCas12a nuclease. This system works in concert with recombinase polymerase amplification (RPA), an isothermal technique that amplifies target DNA without a thermocycler. Upon recognizing the GPV target sequence, the activated Cas12a nuclease cleaves a fluorescently labeled reporter probe, generating a detectable signal. The team achieved dual readout modalities: a fluorescence-based assay and a lateral flow assay (LFA). The results are transformative. The fluorescence-based assay reached a limit of detection (LOD) of 7.8 copies/μL, while the LFA achieved 78 copies/μL [21]. These figures represent a 1000-fold and 100-fold improvement over conventional PCR, respectively. Furthermore, the assay demonstrated absolute specificity, showing no cross-reactivity with other prevalent waterfowl pathogens including duck plague virus, duck hepatitis viruses, H5 avian influenza virus, waterfowl astrovirus, reovirus, MDPV, and even novel GPV (NGPV) [21]. In clinical validation, the LFA results were in complete concordance with laboratory qPCR, affirming its reliability for on-site diagnosis. This dual-readout, ultra-sensitive, and specific CRISPR-based system holds immense promise for the early surveillance and containment of GPV, potentially allowing for real-time decision-making at the farm level.

Serological and Immunodiagnostic Assays

Although molecular detection identifies viral nucleic acid, serological assays are indispensable for monitoring flock immunity, evaluating vaccine efficacy, and conducting epidemiological surveys. The virus neutralization test (VN) has historically been the gold standard for detecting anti-GPV antibodies, but it is labor-intensive, time-consuming, and requires live virus and cell culture facilities [8].

To address these limitations, Tarasiuk et al. [8] developed an indirect enzyme-linked immunosorbent assay (ELISA) using recombinant VP3 subunits as the coating antigen. VP3 is the major structural protein of the GPV capsid and a primary target for the host humoral immune response [2, 15]. By expressing specific VP3 fragments (VP3ep6 and VP3ep4-6) in an Escherichia coli system and purifying them via nickel-affinity chromatography, they created a standardized, non-infectious antigen [8]. The VP3ep4-6 fragment, in particular, showed superior performance, displaying high sensitivity and specificity when validated against a panel of 166 goose sera previously examined by VN. This ELISA method provides a safer, cheaper, and more scalable alternative to VN, suitable for large-scale serosurveillance and monitoring of maternal-derived antibody (MDA) levels in goslings, a critical factor for timing vaccination schedules [8, 13].

Molecular Characterization and Genotyping

Beyond simple detection, molecular diagnostics must characterize circulating strains to track evolution, virulence markers, and the emergence of novel variants like NGPV [16, 18]. This is achieved through PCR amplification followed by sequencing and phylogenetic analysis.

Targeted Gene Sequencing and Phylogenetics: The VP1 gene is a frequent target for phylogenetic studies due to its role in host range and pathogenicity. Soliman et al. [17] used partial VP1 gene sequencing to identify NGPV for the first time in Egypt, clustering the Egyptian isolates with Chinese NGPV strains and distinguishing them from classical GPV. Similarly, Matczuk et al. [18] sequenced the complete coding regions of Polish NGPV isolates from Pekin ducks with SBDS, revealing 98.57-99.28% identity with Chinese NGPV and establishing the first documented outbreak of this variant in Europe. The VP3 gene is another highly informative target, as demonstrated by Chu et al. [15], who used it to show 77% nucleotide similarity between GPV and MDPV, with the most variable region mapping to the N-terminus of VP2. The non-structural (Rep) protein gene is also valuable; Li et al. [14] constructed phylogenetic trees based on both NS and VP1 genes to demonstrate that isolates from older geese (RC45, RC70) formed a distinct branch from classical GPV isolates, while the NGPV strain GXN45 clustered separately.

Full-Genome Analysis and Recombination Detection: The most exhaustive characterization comes from whole-genome sequencing. Işıdan et al. [1] sequenced 4709 nucleotides encompassing structural, non-structural, and ITR regions from Turkish GPV field strains. This approach allowed them to identify a series of unique amino acid substitutions potentially linked to virulence and to confirm that the outbreak strains were of European lineage (Group 2), providing crucial data on transcontinental viral circulation [1]. Full-genome data is also essential for detecting recombination, a major driver of parvovirus evolution. Wang et al. [7] sequenced the entire genome of MDPV strain ZW and used recombination analysis (e.g., RDP4, Bootscan) to demonstrate its mosaic origin, arising from recombination between classical MDPV (major parent) and both virulent and vaccine strains of GPV (minor parents) [7]. This finding underscores the risk of using live attenuated vaccines in areas with high viral circulation and highlights the need for molecular surveillance that can detect such genetic shuffling, which could generate viruses with altered host tropism or virulence.

Analysis of Inverted Terminal Repeats (ITRs) and Cis-Acting Elements: The ITRs are crucial for viral replication and encapsidation. Structural and functional analyses of this region are vital. For example, Wang et al. [11] used infectious clone technology to study a 6-nucleotide E-box motif (CACATG) deletion within the left ITR (L-ITR) of a Muscovy duck-origin GPV. Their work demonstrated that this deletion reduced viral replication and virulence, and it caused cell cycle arrest at the G0/G1 phase in infected cells. This molecular-level characterization, enabled by PCR-based cloning and sequencing of the ITR, directly links specific genetic motifs to viral pathogenesis [11, 14]. Such studies are fundamental for designing safer, rationally attenuated vaccines.

Prevention, Control, and Vaccination Approaches for Derzsy Disease

Derzsy disease, caused by goose parvovirus (GPV) and its antigenically related variants such as novel goose parvovirus (nGPV) and Muscovy duck parvovirus (MDPV), remains one of the most economically devastating viral infections of domestic waterfowl worldwide [1, 13, 16]. The World Organisation for Animal Health (WOAH) recognizes the significant transboundary threat posed by waterfowl parvoviruses, and national veterinary authorities in major goose-producing regions, including Poland, China, Turkey, and Egypt, mandate reporting and implementation of control measures [8, 13, 17]. Effective prevention and control require a multifaceted strategy integrating rigorous biosecurity, passive maternal immunity, strategic vaccination of breeder and replacement flocks, and rapid diagnostic surveillance to detect incursions before clinical disease manifests.

Biosecurity and Management-Based Prevention

The cornerstone of Derzsy disease prevention is strict biosecurity to interrupt both horizontal and vertical transmission pathways. GPV is excreted in high titers in feces and oronasal secretions, and the virus can persist in contaminated environments, equipment, and on fomites, particularly in the presence of organic material [13, 19]. All-in-all-out production systems with thorough cleaning and disinfection between batches are essential. Because GPV can be transmitted vertically through embryonated eggs from infected breeder flocks, sourcing eggs and day-old goslings or ducklings from certified parvovirus-free hatcheries is critical [13]. Quarantine of newly introduced birds for at least 14 days, combined with periodic serological monitoring using validated enzyme-linked immunosorbent assays (ELISAs) such as the VP3ep4–6-based indirect ELISA developed by Tarasiuk et al. [8], allows detection of subclinical carriers and assessment of herd immunity. The VP3ep4–6 ELISA has demonstrated high sensitivity and specificity when compared to virus neutralization tests and is suitable for routine monitoring of maternal antibody levels in offspring and post-vaccination titers in adult flocks [8]. Additionally, rapid on-site molecular diagnostics, including the CRISPR/AsCas12a system (detection limit 7.8 copies/μL) and loop-mediated isothermal amplification (10-fold more sensitive than conventional PCR), enable frontline personnel to identify infected birds within hours, facilitating immediate isolation and containment before horizontal spread occurs [20, 21].

Passive Maternal Immunity: The First Line of Defense

Newly hatched goslings and ducklings are entirely dependent on maternally derived antibodies (MDA) for protection during the first two to three weeks of life, when they are most susceptible to fulminant Derzsy disease [13, 19]. Therefore, ensuring high and uniform antibody titers in breeder flocks is the most effective single intervention to reduce early mortality. Quantitative real-time PCR studies have shown that viral DNA copy numbers in target organs (spleen, heart, liver) correlate inversely with MDA levels, and birds with insufficient passive immunity can harbor high viral loads even before clinical signs appear [19]. Vaccination of breeder hens and drakes with inactivated or modified-live vaccines at least four weeks prior to the laying period boosts MDA transfer to progeny [8, 13]. The durability and titer of MDA can be monitored using the VP3-based ELISA, allowing veterinarians to schedule the timing of active vaccination in young birds once MDA wanes to non-interfering levels [8]. In Poland, where goose production is the largest in Europe, such monitoring is mandated by veterinary authorities to optimize vaccination schedules [8].

Vaccination Platforms and Strategies

Vaccination against GPV has evolved from classical live attenuated and inactivated products to novel recombinant and rationally designed platforms. Commercially available vaccines include modified-live strains (e.g., the SYG61v strain used in China, which unfortunately has also been implicated in recombination events with field strains [7]) and inactivated whole-virus formulations [8, 13]. However, the emergence of antigenically distinct variants, such as the European group 2 strains circulating in Turkey [1], the novel GPV causing short beak and dwarfism syndrome (SBDS) in ducks in China and Europe [14, 17, 18], and recombinant isolates between GPV and MDPV [7], poses challenges to vaccine cross-protection. These variants exhibit unique amino acid substitutions in the VP1 and VP3 capsid proteins that may alter neutralization epitopes [1, 15, 18]. Accordingly, vaccine development must account for the genetic diversity of circulating strains.

Conventional Live and Inactivated Vaccines

Live attenuated vaccines, typically produced by serial passage in goose embryo fibroblasts or embryonated eggs, have been the mainstay of prophylaxis for decades. They induce strong humoral and cell-mediated immunity, but safety concerns include residual virulence, reversion to pathogenicity, and potential for recombination with wild-type virus [7, 13]. Inactivated vaccines are safer but require adjuvants and booster doses to achieve adequate protection and are less effective at inducing mucosal immunity [13]. For example, a commercial vaccine evaluated in parallel with a recombinant Lactobacillus casei oral vaccine provided only 30% protection in gosling challenge studies [3], highlighting the need for improved immunogenicity.

Recombinant and Vector-Based Vaccines

The VP3 capsid protein, which constitutes the major antigenic domain of GPV, has been the target of advanced vaccine designs. Chen et al. [3] constructed recombinant L. casei expressing the GPV VP3 gene. Following oral immunization of goslings, the recombinant bacterium colonized the intestine for approximately 34 days and elicited both systemic (IgG) and mucosal (sIgA) antibody responses, as well as enhanced transcriptional levels of cytokines (IL-2, IL-4, IFN-γ) in various tissues. Despite inducing robust immune activation, the protective efficacy against lethal challenge was 30%, identical to that of the commercial vaccine tested in the same study [3]. This suggests that while the oral L. casei platform is safe, easy to administer, and suitable for mass vaccination, further optimization, such as co-expression of immunomodulatory molecules, multivalent display, or use of stronger promoters, is required to elevate protection levels.

Virus-like particles (VLPs) represent another promising platform. The recent cryo-EM structure of the GPV capsid at 2.4 Å resolution revealed that GPV VLPs assemble spontaneously from VP1, VP2, and VP3 [2]. These VLPs are thermally stable at physiological pH and display surface-accessible variable regions (VRs) that are unique among dependoparvoviruses. Specifically, VR-III was identified as critical for host cell infection in both GPV and MDPV [2]. VLPs can be engineered to present these VRs in their native conformation, potentially inducing neutralizing antibodies that block receptor binding and entry. Moreover, VLPs lack viral nucleic acid, eliminating reversion risk. Although no commercial GPV VLP vaccine currently exists, the structural data provide a rational basis for epitope-focused immunogen design.

Reverse Genetics and Attenuation by Rational Design

The development of infectious clones and reverse genetics systems for GPV has opened avenues for constructing precisely attenuated vaccine strains. Liu et al. [10] demonstrated that mutation of three lysine residues (K164A, K165A, K167A) in the nuclear localization signal (NLS) of VP1, within the conserved motif ¹⁶⁰YPVVKKPKLTEE¹⁷¹, completely abolished nuclear import of VP1 and abrogated viral proliferation in goose embryo fibroblasts. Because VP1 nuclear localization is essential for genome delivery and progeny virus assembly [12], such mutants are replication-incompetent and could serve as safe, non-reverting vaccine candidates. Similarly, deletion of an E-box motif (CACATG) in the left inverted terminal repeat (L-ITR) of a Muscovy duck-origin GPV strain reduced virulence and replication ability in duck embryos, while inducing cell cycle arrest at G0/G1 phase that further limited viral progeny production [11]. These molecular markers of attenuation offer a path toward improved live vaccines with defined genetic signatures.

Integrated Control and Surveillance

No single intervention is sufficient to eradicate Derzsy disease from endemic regions. An integrated control program must combine biosecurity, vaccination of breeders and offspring, and active surveillance using molecular and serological tools. The emergence of co-infections, such as GPV plus goose astrovirus, which exacerbates visceral gout and immunosuppression [6], or GPV plus duck circovirus, which impairs immune responses to vaccination [18], complicates control efforts. Therefore, routine health monitoring should include multiplex diagnostics that can detect multiple pathogens simultaneously. The CRISPR/AsCas12a-based lateral flow assay described by Xiao et al. [21] is particularly well-suited for field deployment in low-resource settings; it achieved 100% concordance with laboratory qPCR and detected GPV at 78 copies/μL without cross-reactivity with other common waterfowl viruses.

Given the increasing detection of nGPV causing SBDS in Pekin and mule ducks across Europe and Asia [17, 18], vaccines currently licensed for classical GPV may need to be evaluated for efficacy against these novel genotypes. Sequence analyses reveal that nGPV isolates share only 96.42% nucleotide identity with classical GPV in coding regions, with unique mutations in the Rep and VP1 proteins that could alter antigenicity [18]. Proactive surveillance and periodic updating of vaccine seed strains, similar to the approach used for influenza viruses, should be institutionalized.

In conclusion, the prevention and control of Derzsy disease demand a hierarchical approach: robust biosecurity to exclude the virus, passive immunity from vaccinated breeders to protect neonates, strategic active immunization with either commercial or next-generation recombinant vaccines, and rapid molecular diagnostics to enable early containment. The recent structural, immunological, and reverse genetics advances provide a powerful foundation for developing safer and more broadly protective vaccines against both classical GPV and its emerging variants. National veterinary authorities, in alignment with WOAH guidelines, should prioritize vaccination of breeder flocks and implement surveillance programs that can detect incursions at the earliest possible stage, thereby safeguarding the economic viability of the global waterfowl industry.

References

[1] Işıdan H, Turan T, Atasoy M, Coşkun A. Molecular analysis of goose parvovirus field strains from the Derzsy’s disease outbreak revealed the local European-associated variants. . 2021. DOI: https://doi.org/10.21203/RS.3.RS-260589/V1

[2] Jabbari K, Mietzsch M, Hsi J, Chipman P, Qiu J, McKenna R. The Structural, Biophysical, and Antigenic Characterization of the Goose Parvovirus Capsid. Microorganisms. 2025. DOI: https://doi.org/10.3390/microorganisms13010080

[3] Chen Y, Pei Y, Yu Q, Dong H, Jin L. The construction and immune efficacy of recombinant Lactobacillus casei strains expressing VP3 from goose parvovirus. Veterinarski arhiv (Tisak). 2024. DOI: https://doi.org/10.24099/vet.arhiv.2461

[4] Sallam H, Nour AAH, Zanaty A. Involvement of Goose Parvovirus in Induction of Angel Wing Syndrome in Muscovy Ducks. Avian diseases. 2022. DOI: https://doi.org/10.1637/aviandiseases-D-22-00014

[5] Bulut O, Dik I, Aslım HP, Avci C, Palancı HS, Akbaba S, et al.. Molecular characterization of goose parvovirus in geese of Turkey. Pesquisa Veterinária Brasileira. 2021. DOI: https://doi.org/10.1590/1678-5150-pvb-6903

[6] Liu M, Zhao Y, Hu D, Huang X, Xiong H, Qi K, et al.. Clinical and Histologic Characterization of Co-infection with Astrovirus and Goose Parvovirus in Goslings.. Avian diseases. 2019. DOI: https://doi.org/10.1637/AVIANDISEASES-D-19-00110

[7] Wang J, Ling J, Wang Z, Huang Y, Zhu J, Zhu G. Molecular characterization of a novel Muscovy duck parvovirus isolate: evidence of recombination between classical MDPV and goose parvovirus strains. BMC Veterinary Research. 2017. DOI: https://doi.org/10.1186/s12917-017-1238-6

[8] Tarasiuk K, Holec-Gąsior L, Ferra B, Rapak A. The development of an indirect ELISA for the detection of goose parvovirus antibodies using specific VP3 subunits as the coating antigen. BMC Veterinary Research. 2019. DOI: https://doi.org/10.1186/s12917-019-2027-1

[9] Liu H, Yang C, Liu M, Ma K, Huang X, Zhao Y, et al.. Pathological lesions in the immune organs of ducklings following experimental infection with goose parvovirus.. Research in Veterinary Science. 2019. DOI: https://doi.org/10.1016/j.rvsc.2019.06.002

[10] Liu P, Yang L, Zhang J, Wang T, Wu Y, Wang M, et al.. The 164 K, 165 K, and 167 K residues of VP1 are vital for goose parvovirus proliferation in GEFs based on PCR-based reverse genetics system. Virology Journal. 2019. DOI: https://doi.org/10.1186/s12985-019-1237-2

[11] Wang S, Xiao S, Cheng X, Chen S, Zhu X, Lin F, et al.. Recovery of Muscovy duck-origin goose parvovirus from an infectious clone containing an E-box motif (CACATG) deletion within the left terminal region.. Molecular and Cellular Probes. 2019. DOI: https://doi.org/10.1016/j.mcp.2019.05.006

[12] Chen S, Liu P, He Y, Yang C, Wang M, Jia R, et al.. The 164 K, 165 K and 167 K residues in 160YPVVKKPKLTEE171 are required for the nuclear import of goose parvovirus VP1.. Virology. 2018. DOI: https://doi.org/10.1016/j.virol.2018.03.020

[13] El-Ghany WAA. PARVOVIRUS INFECTION: A THREAT TO DOMESTIC WATERFOWL INDUSTRY. Assiut veterinary medical journal. 2025. DOI: https://doi.org/10.21608/avmj.2025.365981.1611

[14] Li D, Zhang L, Chen S, Gu J, Ding M, Li J. Detection and Molecular Characterization of Two Genotypes of Goose Parvoviruses Isolated from Growing Period Geese and Cherry Valley Ducks in China. Avian diseases. 2019. DOI: https://doi.org/10.1637/12015-121818-Reg.1

[15] Chu C, Pan M, Cheng JT. Genetic variation of the nucleocapsid genes of waterfowl parvovirus.. Journal of Veterinary Medical Science. 2001. DOI: https://doi.org/10.1292/JVMS.63.1165

[16] Chen Y, Afumba R, Pang F, Yuan R, Dong H. Advances in Research on Genetic Relationships of Waterfowl Parvoviruses. Journal of Veterinary Research. 2021. DOI: https://doi.org/10.2478/jvetres-2021-0063

[17] Soliman M, Erfan A, Samy M, Mahana O, Nasef S. Detection of Novel Goose Parvovirus Disease Associated with Short Beak and Dwarfism Syndrome in Commercial Ducks. Animals. 2020. DOI: https://doi.org/10.3390/ani10101833

[18] Matczuk A, Chmielewska-Władyka M, Siedlecka M, Bednarek KJ, Wieliczko A. Short Beak and Dwarfism Syndrome in Ducks in Poland Caused by Novel Goose Parvovirus. Animals. 2020. DOI: https://doi.org/10.3390/ani10122397

[19] Woźniakowski G, Samorek-Salamonowicz E, Kozdruń W. Quantitative analysis of waterfowl parvoviruses in geese and Muscovy ducks by real-time polymerase chain reaction: correlation between age, clinical symptoms and DNA copy number of waterfowl parvoviruses. BMC Veterinary Research. 2012. DOI: https://doi.org/10.1186/1746-6148-8-29

[20] Tarasiuk K, Woźniakowski G, Samorek-Salamonowicz E. Loop-Mediated Isothermal Amplification as a Simple Molecular Method for the Detection of Derzsy’s Disease Virus. Journal of Veterinary Research. 2013. DOI: https://doi.org/10.2478/BVIP-2013-0004

[21] Xiao Y, Yang J, Yang W, Yuan M, Zhang Y, Liu J, et al.. A rapid on-site diagnostic method for goose parvovirus disease based on recombinase polymerase amplification and CRISPR/AsCas12a.. International Journal of Biological Macromolecules. 2026. DOI: https://doi.org/10.1016/j.ijbiomac.2026.150496